Michael Garippa Announced as SynCardia's New CEO
Former SynCardia CEO Rodger Ford Joins MicroMed Cardiovascular as Chairman and CEO
TUCSON, Ariz. – May 18, 2011 – SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, announced today that Rodger Ford, the company's CEO for the past six years, has stepped down. SynCardia President Michael Garippa has taken over as CEO in addition to his current role. Mr. Ford is joining MicroMed Cardiovascular, Inc. manufacturer of the HeartAssist 5™ left ventricular assist device, as CEO and Chairman of the Board.
"I have always provided advice to others that 'it is important to know your pathway to exit before you enter.'" said Mr. Ford. "When I recruited Michael to join SynCardia as President in July 2010, it was the first step of my plan to have him gradually transition to replace me as CEO. Michael has made a remarkable contribution, and month after month the company has exceeded its sales target. SynCardia more than doubled its revenue in 2010 compared to 2009."
Prior to joining SynCardia, Mr. Garippa served as the CEO and President of TandemHeart for eight years. He was recruited by TandemHeart in 2002 as a turnaround expert and stayed on as CEO and President. He took the company from an R&D firm that had lost an aggregate of $50 million and had no commercial sales to a successful company with over $6 million in net income during his last two years with the company.
"Rodger transformed SynCardia from a R&D company that served a handful of hospitals to a successful company and industry leader in biventricular replacement, serving some of the top transplant programs around the world," said Mr. Garippa. "This is a very exciting time at SynCardia. The company continues to pick up velocity and traction as we work to complete the FDA-approved Investigational Device Exemption clinical study of the Freedom® portable driver."
Mr. Ford became a director of SynCardia in May 2004. SynCardia received FDA approval of the Total Artificial Heart in October that year. In July 2005, Mr. Ford became the CEO and President. He joined the board of directors for MicroMed Cardiovascular in July 2008. Mr. Ford brings more than 40 years of entrepreneurial accomplishments and leadership to MicroMed, having founded numerous companies including AlphaGraphics Printshops Of The Future, PetsHotel and Anthem Equity Group, Inc.
"I will be forever grateful to the dedicated individuals that have lifted SynCardia on their backs and have carried us forward," said Mr. Ford. "As a significant investor and board member, I will continue to support the best interests of SynCardia.
SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart for use as a bridge to transplant for people suffering from end-stage biventricular heart failure in which both ventricles can no longer pump enough blood for a person to survive.
More than 1,350 implants of the SynCardia Total Artificial Heart accounts for over 400 patient years of life on the device. Since January 2011 more than 400 SynCardia Hearts have been implanted.
The youngest patient to receive a SynCardia Heart was 9 years old; the oldest was 76 years old. The longest a patient has lived with a SynCardia Heart was nearly four years (1,374 days) before receiving a successful donor heart transplant September 11, 2011.
SynCardia Systems also manufactures the Freedom® portable driver, which powers the SynCardia Heart while allowing clinically stable patients to leave the hospital to live at home and in their communities. The wearable Freedom driver has been used by more than 190 patients, accounting for over 110 years of support